ライフサイエンスコーパス: at delivery

1 status of the placenta can only be assessed at delivery.

2 rd level was 66% of the maternal serum level at delivery.

3 l blood and placental samples were retrieved at delivery.

4 specimens from 293 pregnant Mozambican women at delivery.

5 de pair implanted 1 mm away from the site of AT delivery.

6 k of preterm delivery and uterine dehiscence at delivery.

7 n newborns of women with and without malaria at delivery.

8 Standardized evaluations were performed at delivery.

9 were detected over the course of therapy or at delivery.

10 d of women with or without placental malaria at delivery.

11 s in clinical parameters at midpregnancy and at delivery.

12 estation; umbilical cord blood was collected at delivery.

13 BL levels were measured during pregnancy and at delivery.

14 stology) and maternal peripheral parasitemia at delivery.

15 normotensive (n=42) pregnant women recruited at delivery.

16 r contamination with infected maternal blood at delivery.

17 tal status, and maternal county of residence at delivery.

18 borns of multigravid and/or uninfected women at delivery.

19 tus, age, fetal growth, or week of gestation at delivery.

20 respectively but only 49% (95% CI, 31%, 66%) at delivery.

21 ive hallucinations, and intermittent amnesia at delivery.

22 prenatal care, or had longer hospital stays at delivery.

23 , in part, by the postnatal rise in cortisol at delivery.

24 g an underreporting of psychiatric disorders at delivery.

25 or the 107 women who had undetectable levels at delivery.

26 ed in serial maternal samples and cord blood at delivery.

27 livery; and the presence of chorioamnionitis at delivery.

28 7 (49.4%) were to women enrolled in Medicaid at delivery.

29 (2%) of 33,376 babies, were judged abnormal at delivery.

30 virus populations taken during pregnancy and at delivery.

31 nary arteries, and increased the fall in PVR at delivery.

32 f maternal blood obtained at study entry and at delivery.

33 rritin or hepcidin as iron-status indicators at delivery.

34 cantly negatively associated with hemoglobin at delivery.

35 ated with higher fetal loss and more malaria at delivery.

36 t trimester, during the third trimester, and at delivery.

37 ups were a mean (SD) age of 28.9 (5.1) years at delivery.

38 e is rectovaginal colonisation of the mother at delivery.

39 mens, and cord blood specimens were obtained at delivery.

40 ropoietin is a sensitive predictor of anemia at delivery.

41 ir showed improvement in HBV DNA suppression at delivery.

42 ted HAART during pregnancy had detectable VL at delivery.

43 should be considered when assessing VTE risk at delivery.

44 rence were more likely to have detectable VL at delivery.

45 doses of IPTp but rebounded to 34% (by PCR) at delivery.

46 . falciparum infection and hemoglobin levels at delivery.

47 factors; and detectable VL (>400 copies/mL) at delivery.

48 , and BPD at weeks 20-34, and with BW and HC at delivery.

49 d matching maternal blood samples were taken at delivery.

50 others who had Plasmodium falciparum malaria at delivery.

51 clusion criteria and 13.1% had detectable VL at delivery.

52 regnancy, were associated with detectable VL at delivery.

53 (PTH) in maternal circulation and cord blood at delivery.

54 hy eating, and exercise and was discontinued at delivery.

55 CI: -5.91, 2.44) than a positive urine test at delivery (-182 g (95% CI: -295, -69.8) and -6.11 mm (

56 creased the odds of stillbirth when detected at delivery (2.81 [0.77-10.22]; three estimates), but no

57 ot differ between groups during gestation or at delivery: 24 women in the iodine group and 28 in the

58 in maternal and cord blood samples obtained at delivery (251 maternal-newborn pairs), and birth weig

59 ernal samples in early pregnancy (12-16 wk), at delivery (28-42 wk), and in cord blood.

60 standard care (mean [+/-SD] gestational age at delivery, 30.8+/-2.0 weeks vs. 37.0+/-1.5 weeks; P<0.

61 ysis of serotype-specific antibody responses at delivery (+72 h) for use in subsequent studies.

62 differ significantly among the three groups at delivery (96% in the NRTI group, 93% in the protease-

63 th-weight percentile and the gestational age at delivery; after adjustment for these factors, the odd

64 Cord plasma at delivery also had higher concentrations of d3-RRR-alp

65 ll women with malaria are still parasitaemic at delivery, an estimated 20% of the 1 059 700 stillbirt

66 blood, cervical secretions, and breast milk at delivery and 1 month after delivery.

67 4 weeks after Tdap immunization or placebo, at delivery and 2 months' postpartum, and in infants at

68 s after dose 2, and, in mothers and infants, at delivery and 3 and 6 months postdelivery.

69 s by delivery companies to verify their ages at delivery and 95% of delivered orders simply left at t

70 , periodontal treatment, and gestational age at delivery and birth weight.

71 s (P <.05) when adjusted for gestational age at delivery and birth weight.

72 Infant gestational age at delivery and changes in maternal bra cup size between

73 om two studies in which maternal PFAS levels at delivery and children's PFAS levels were available.

74 peripheral, placental, cord blood specimens) at delivery and composite birth outcome (small for gesta

75 vudine improved maternal HBV DNA suppression at delivery and during 4-8 weeks' postpartum follow-up.

76 osed to malarial antigens either in utero or at delivery and have the potential to produce antimalari

77 ogical endpoints such as placental infection at delivery and health outcomes including birthweight, w

78 Thyroid hormone levels were also assessed at delivery and in cord blood (n = 260).

79 of specific antibody in mother-infant pairs at delivery and in infants at 16 weeks, determined by en

80 mothers at 15 and 28 weeks of pregnancy and at delivery and in their infants in umbilical cord blood

81 ts were measured in blood samples from women at delivery and in umbilical cords, and in infants for e

82 disturbance was unrelated to gestational age at delivery and persisted for up to 1 y.

83 ad longitudinal testing, with repeat testing at delivery and postpartum and additional cytokines meas

84 n were recruited into a retrospective cohort at delivery and tested for syphilis.

85 icance included a higher maternal virus load at delivery and the presence of cocaine in the urine.

86 PT was analyzed according to maternal VL at delivery and timing of ART initiation.

87 Secondary endpoints were VL at delivery and tolerance.

88 versus pregnant women (during pregnancy, not at delivery) and by gravidity, and we used meta-regressi

89 .6% of women studied (n = 37/83) were anemic at delivery, and 18% of women (n = 11/61) had IDA.

90 regnancy had a 2-fold greater risk of anemia at delivery, and 25% (n = 5) developed iron deficiency a

91 fore vaccination, 1 month after vaccination, at delivery, and at postpartum week 24 in mothers and wi

92 placental malaria, maternal hemoglobin level at delivery, and birth weight.

93 ore vaccination (day 1), day 15, day 31, and at delivery, and in infants at birth and day 42 of life.

94 birth during the same year, gestational age at delivery, Apgar score at 5 minutes, maternal and pate

95 pregnancy ( approximately 24 wk; n = 73) and at delivery ( approximately 35 wk; n = 61) were used to

96 Antiparasite IgGs in women at delivery are affected by HIV infection, as well as by

97 others had a malaria-infected placenta (MIP) at delivery are at increased risk of a first malaria inf

98 atally, ECMO requirement and gestational age at delivery are useful in further improving the estimate

99 ts born to mothers who were HCV RNA positive at delivery became infected, compared with 0 of 54 infan

100 n aged over 10 years, with a gestational age at delivery between 22 and 44 weeks, and excluded deaths

101 edical record data included gestational week at delivery, birth weight, resuscitation, neonatal inten

102 nal and cord plasma from 259 Caucasian women at delivery (BMI 18-55 kg/m(2)).

103 or infants born to mothers with low ferritin at delivery, breastfed infants not receiving iron-fortif

104 ignificantly associated with gestational age at delivery but not with fetal sex.

105 birthweight is low for their gestational age at delivery, but past analyses have been hampered by sma

106 n significantly decreased the risk of anemia at delivery by 40% (RR, 0.60; 95% CI, 0.51-0.71) but not

107 reduced the risk of maternal iron deficiency at delivery by 52% (RR, 0.48; 95% CI, 0.32-0.70) and the

108 ctions were assessed in 272 Mozambican women at delivery by microscopy, placental histology, quantita

109 Birth outcomes were completed at delivery by midwives who also collected cord blood sa

110 this study was to test whether maternal age at delivery, child's birth order, cesarean section, comp

111 3), 10.5% among women with malaria infection at delivery compared to 7.9% among uninfected women (aRR

112 ion had improved hematologic and iron status at delivery compared with the placebo group.

113 dministration, preeclampsia, gestational age at delivery, days in intensive care unit, sex, age, and

114 y and mortality increases as gestational age at delivery decreases.

115 The primary outcome was malaria infection at delivery, defined as a composite of peripheral or pla

116 ensity was calculated as actual birth weight at delivery divided by fetal body volume at MR imaging i

117 At delivery, ECGs were recorded and analyzed for conduct

118 her GMCs than did those in the placebo group at delivery (eg, GMCs against serotype Ia were 11 mug/mL

119 GMCs of maternal antibodies at delivery (ELISA units/mL) were 2.4 for PT, 6.9 for FH

120 is necessary to screen for domestic violence at delivery, especially for women who may not have obtai

121 ts may be more vulnerable to HIV acquisition at delivery, especially if membrane rupture is prolonged

122 RI)] and placental active transport capacity at delivery [fetal to maternal measles antibody (MMA) ra

123 Six of these samples were male at delivery, five had inconclusive results for SRY analy

124 Data were available at delivery for 2356 women, with 2345 livebirths; 2115 (

125 ternal and cord blood samples were collected at delivery for DNA extraction.

126 nt women in their second/third trimester and at delivery for LTBI using the tuberculin skin test (TST

127 =55) Mozambican pregnant women were assessed at delivery for maternal and cord P. falciparum infectio

128 HIV-viral load was measured at delivery for mothers and at 6 weeks of age for infant

129 ed maternal and umbilical cord blood samples at delivery from 622 mother-infant pairs residing near a

130 Plasma samples obtained at delivery from 885 pregnant Ghanaian women were tested

131 ples were taken from 201 pregnant women and, at delivery, from the umbilical cord veins of their heal

132 ding birthweight, birth length, parental age at delivery, gestational age, intrauterine exposure to d

133 Maternal plasma and lipoproteins obtained at delivery had higher concentrations of d3-RRR-alpha-to

134 The use of a polyethylene wrap applied at delivery has been shown to reduce the occurrence of h

135 At delivery, high IL-10 levels in maternal blood were as

136 At delivery, HIV-infected mothers and their infants were

137 an antibody concentration in blood collected at delivery); however, at birth, maternally derived sero

138 blood-derived maternal virus genotypes found at delivery if infants were found to be infected only so

139 d at midgestation ( approximately 26 wk) and at delivery in 171 adolescents (</= 18 y).

140 and plasma was measured during gestation and at delivery in mothers who did and did not transmit HIV

141 d maternal or placental plasmodium infection at delivery in multigravidae (third pregnancy or higher)

142 ticoids are lower in maternal and cord blood at delivery in obese pregnancies.

143 Plasmodium falciparum malaria detected at delivery in peripheral samples increased the odds of

144 y (time-varying treatment) on odds of anemia at delivery in the presence of time-dependent confoundin

145 ations of pertussis antibodies were measured at delivery in women who received Tdap during pregnancy

146 At delivery, in both analyses, we observed negative asso

147 ve been described in placenta and cord blood at delivery, in fetal lung, and in buccal epithelium and

148 vast majority of women with low viral loads at delivery, in the absence of obstetrical risk factors,

149 roughout the course of pregnancy, as well as at delivery, in women with asymptomatic infections and t

150 tcomes were birth weight and gestational age at delivery, intrauterine growth, and maternal and infan

151 Among 6099 women at delivery, IPTp-SP was associated with a 22% reduction

152 ine whether older or very young maternal age at delivery is associated with mental retardation in chi

153 Whether this is maintained at delivery is unknown but is clinically relevant as mat

154 Conditions at delivery may overcome any potential negative effects

155 sis had an earlier estimated gestational age at delivery (mean, 38.6 weeks; 95% CI, 38.2-38.9) than t

156 We collected maternal and cord blood at delivery, measured manganese using inductively couple

157 present in 67% of mothers and 65% of infants at delivery (median 66 days after dose 2), 60% of mother

158 Despite low maternal folate status at delivery (median: 9.0 nmol/L), with 35% of women in t

159 At delivery, median durations of ART were 13 weeks (IQR,

160 The mothers' own pups were removed at delivery; mothers were nonmaternal at the time of tes

161 n was noted in paired maternal-blood samples at delivery (n=16) or amplicon levels in cord-blood samp

162 confidence interval, 1.2 to 4.7; P=0.02) and at delivery (odds ratio, 3.4; 95 percent confidence inte

163 dence interval) (in mug/L) in maternal serum at delivery of PFOS [8.50 (7.01-9.58)] and PFOA [3.43 (3

164 relate with CD4 cell count or HIV-1 RNA load at delivery or with type of antepartum antiretroviral th

165 OR, 3.38 [95% CI, 1.65-6.93]) and viral load at delivery (OR, 2.35 [95% CI, 1.62-3.40]) independently

166 er liter or more, intubation for ventilation at delivery, or neonatal encephalopathy.

167 maternal hemoglobin at both midgestation and at delivery (P < 0.01 for both).

168 nation (ECMO) (P < .001) and gestational age at delivery (P = .009).

169 as inversely correlated with gestational age at delivery (P = 0.0039).

170 03 and 5116] HIV-1 RNA copies per milliliter at delivery; P < .001) and none transmitted.

171 , ancestry, neonatal gender, gestational age at delivery, parity, maternal age at oral glucose tolera

172 d with nevirapine resistance were detectable at delivery, prior to receipt of study drug, in 5 (2.3%)

173 At delivery, proportions with VL <200 copies/mL were sim

174 epregnancy BMI, marital status and insurance at delivery, race, smoking during target pregnancy, and

175 s calculated as the enrichment in cord blood at delivery relative to maternal serum enrichment 2 h po

176 od samples were obtained at midgestation and at delivery, respectively.

177 (2721, 2867 nmol/L ) in early pregnancy and at delivery, respectively.

178 independent risk factors, in addition to GA at delivery, SGA, multiple births, and male sex.

179 At delivery, significantly lower HBV DNA levels were not

180 own risk factors (i.e., gestational age [GA] at delivery, small for gestational age [SGA], multiple b

181 is multifactorial, high maternal virus load at delivery strongly predicts transmission.

182 51 vs 0.16 Mn:Ca, p < 0.001), maternal blood at delivery than 26 weeks gestation (GM = 20.7 vs. 14.6

183 4.3-fold higher median plasma HIV RNA level at delivery than did nontransmitters (P<.001).

184 vels higher than 50000 copies per milliliter at delivery than nontransmitting mothers (15 [75.0%] of

185 kely to have aNAB to their own HIV-1 strains at delivery than nontransmitting mothers (n = 17, 14.3%

186 ificantly lower HIV-1 quasispecies diversity at delivery than untreated nontransmittting mothers (n =

187 38 days the anaemic fetuses were transfused; at delivery the haematocrit was 29.3 +/- 6.8 % compared

188 At delivery, the infant also had vitamin A deficiency.

189 At delivery, the LNS (n = 1184) and control (n = 1185) g

190 parity, and the offspring's gestational age at delivery, the odds ratio for an adult whose mother ha

191 In this longitudinal study of malaria at delivery, the receipt of SP as IPTp did not potentiat

192 At delivery, the TDF group had lower maternal HBV DNA le

193 weeks gestation and placental and cord blood at delivery to assess inflammatory status.

194 We screened 128,049 pregnant women at delivery to identify three groups of infants: those e

195 , and Nutrition study were randomly assigned at delivery to receive: LNS, ARV, LNS and ARV, or a cont

196 has been widely prescribed to pregnant women at delivery, to reduce mother-to-child transmission of h

197 ions of DEHP metabolites and gestational age at delivery using linear regression models and associati

198 an plasma viral load of 65,516 RNA copies/mL at delivery versus 5139 in nontransmitting women.

199 heir infection to their children in utero or at delivery (vertical transmission).

200 ere female, and the median (SD) maternal age at delivery was 25 (6) years.

201 Mean (SD) age at delivery was 29.5 (5.3) years.

202 The weight at delivery was 3.5 +/- 0.36 kg in the anaemic fetuses v

203 The median gestational age at delivery was 30.7 weeks (IQR 29.1-32.1) and mean birt

204 Mean birthweight at delivery was 3463 g (SD 660) in the placebo group and

205 Mean gestational age at delivery was 37 weeks, with 100% survival.

206 The mean gestational age at delivery was 38 weeks.

207 e at enrollment and race, the odds of anemia at delivery was 8 times greater in adolescents with deli

208 Malaria parasitemia at delivery was associated with an adjusted decrease in

209 The estimated gestational age at delivery was earlier for study patients (33.2 vs 37.0

210 Venous cord blood collected at delivery was evaluated for transplacental transfer of

211 The prevalence of malaria at delivery was higher in the ISTp-DP arm (48.7% versus

212 HIV viral load at delivery was higher in the MQ group compared to the c

213 Prevalence of malaria infection at delivery was lower in the intermittent preventive tre

214 A detectable HIV-viral load at delivery was more common among pregnant women with tu

215 A positive hair test at delivery was not more strongly associated with birth

216 Gestational age at delivery was significantly greater in those who recei

217 istance, adjusted for plasma viral RNA level at delivery, was not strongly associated with an increas

218 Of 17,046 women enrolled at delivery, we assessed 11,867 women (69.6%) at 11.5 y

219 At delivery, we collected a placental-tissue sample and

220 SRY real time PCR results and fetal sex at delivery were 100% accurate.

221 ts, for which the mean (SD) gestational ages at delivery were 38.4 (2.1) weeks, 35.8 (2.8) weeks, and

222 and umbilical cord plasma samples collected at delivery were analyzed for medication concentrations.

223 Outcomes at delivery were as follows: normal placenta (n = 11), h

224 There was no evidence that MBL levels at delivery were associated with malaria-related poor pr

225 Pregnancies with OP positions at delivery were compared with those with occiput anteri

226 Matched maternal and neonatal sera obtained at delivery were functionally equivalent in an in vitro

227 Plasma HIV RNA levels at delivery were higher among transmitters (mean, 68,921

228 primary results for participants and infants at delivery were published in 2012; we present results f

229 rinated biphenyls in maternal serum and milk at delivery were slightly higher than in the general pop

230 Mother-neonate paired serum samples at delivery were tested for IgG to antigens from P. falc

231 (1) When anal sphincter injury occurs at delivery, what is the most effective method of repair

232 aternal tHcy was lower during pregnancy than at delivery, whereas folate and vitamin B-12 status decl

233 Inflammation was present at delivery, which limited the utility of ferritin or he

234 8, 19.4) of the variation in gestational age at delivery, while maternal genetic factors accounted fo

235 relatively homogeneous across all body sites at delivery, with the notable exception of the neonatal